TCL Archive Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy July 26, 2013
TCL Archive Women’s Health Trial Committee Hears New Analysis Of Vanguard Groups, Other Data January 1, 1988